CD209 and glioblastoma: In addition, the enzymatic removal of sialic acids in glioblastoma-derived EVs led to their enhanced EV uptake by dendritic cells also in a DC-SIGN dependent manner, and the activation of both CD8+ and CD4+ T cell responses [45].